Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Equity Average (2020 - 2025)

Historic Equity Average for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $93.4 million.

  • Treace Medical Concepts' Equity Average fell 1393.48% to $93.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.4 million, marking a year-over-year decrease of 1393.48%. This contributed to the annual value of $125.4 million for FY2024, which is 2638.37% up from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' Equity Average is $93.4 million, which was down 1393.48% from $101.5 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Equity Average ranged from a high of $153.8 million in Q2 2023 and a low of $46000.0 during Q1 2021
  • Its 5-year average for Equity Average is $98.0 million, with a median of $101.5 million in 2025.
  • Over the last 5 years, Treace Medical Concepts' Equity Average had its largest YoY gain of 19543369.57% in 2022, and its largest YoY loss of 3555.65% in 2022.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Equity Average stood at $95.2 million in 2021, then tumbled by 35.56% to $61.4 million in 2022, then surged by 124.72% to $137.9 million in 2023, then fell by 21.03% to $108.9 million in 2024, then dropped by 14.23% to $93.4 million in 2025.
  • Its Equity Average was $93.4 million in Q3 2025, compared to $101.5 million in Q2 2025 and $109.1 million in Q1 2025.